201 related articles for article (PubMed ID: 1920361)
1. Development of a small RGD peptide fibrinogen receptor antagonist with potent antiaggregatory activity in vitro.
Samanen J; Ali F; Romoff T; Calvo R; Sorenson E; Vasko J; Storer B; Berry D; Bennett D; Strohsacker M
J Med Chem; 1991 Oct; 34(10):3114-25. PubMed ID: 1920361
[TBL] [Abstract][Full Text] [Related]
2. The in vitro pharmacological profile of SK&F 106760, a novel GPIIB/IIIA antagonist.
Nichols AJ; Vasko JA; Valocik RE; Kopaciewicz LJ; Storer BL; Ali FE; Romoff T; Calvo R; Samanen JM
Thromb Res; 1994 Jul; 75(2):143-56. PubMed ID: 7974388
[TBL] [Abstract][Full Text] [Related]
3. Conformationally constrained peptides and semipeptides derived from RGD as potent inhibitors of the platelet fibrinogen receptor and platelet aggregation.
Ali FE; Bennett DB; Calvo RR; Elliott JD; Hwang SM; Ku TW; Lago MA; Nichols AJ; Romoff TT; Shah DH
J Med Chem; 1994 Mar; 37(6):769-80. PubMed ID: 8145226
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of integrin-mediated platelet aggregation, fibrinogen-binding, and interactions with extracellular matrix by nonpeptidic mimetics of Arg-Gly-Asp.
Varon D; Lider O; Dardik R; Shenkman B; Alon R; Hershkoviz R; Kapustina G; Savion N; Martinowitz U; Greenspoon N
Thromb Haemost; 1993 Dec; 70(6):1030-6. PubMed ID: 8165596
[TBL] [Abstract][Full Text] [Related]
5. Design of orally active, non-peptide fibrinogen receptor antagonists. An evolutionary process from the RGD sequence to novel anti-platelet aggregation agents.
Bovy PR; Tjoeng FS; Rico JG; Rogers TE; Lindmark RJ; Zablocki JA; Garland RB; McMackins DE; Dayringer H; Tóth MV
Bioorg Med Chem; 1994 Sep; 2(9):881-95. PubMed ID: 7712124
[TBL] [Abstract][Full Text] [Related]
6. Antithrombotic properties of L-cysteine, N-(mercaptoacetyl)-D-Tyr-Arg-Gly-Asp-sulfoxide (G4120) in a hamster platelet-rich femoral vein thrombosis model.
Imura Y; Stassen JM; Bunting S; Stockmans F; Collen D
Blood; 1992 Sep; 80(5):1247-53. PubMed ID: 1515641
[TBL] [Abstract][Full Text] [Related]
7. A three-residue cyclic scaffold of non-RGD containing peptide analogues as platelet aggregation inhibitors: design, synthesis, and structure--function relationships.
Stavrakoudis A; Bizos G; Eleftheriadis D; Kouki A; Panou-Pomonis E; Sakarellos-Daitsiotis M; Sakarellos C; Tsoukatos D; Tsikaris V
Biopolymers; 2000-2001; 56(1):20-6. PubMed ID: 11582574
[TBL] [Abstract][Full Text] [Related]
8. Cyclic RGD peptide analogues as antiplatelet antithrombotics.
Barker PL; Bullens S; Bunting S; Burdick DJ; Chan KS; Deisher T; Eigenbrot C; Gadek TR; Gantzos R; Lipari MT
J Med Chem; 1992 May; 35(11):2040-8. PubMed ID: 1597855
[TBL] [Abstract][Full Text] [Related]
9. Discovery and structure--activity relationship studies of a novel and specific peptide motif, Pro-X-X-X-Asp-X, as a platelet fibrinogen receptor antagonist.
Hayashi Y; Katada J; Sato Y; Igarashi K; Takiguchi Y; Harada T; Muramatsu M; Yasuda E; Uno I
Bioorg Med Chem; 1998 Mar; 6(3):355-64. PubMed ID: 9568289
[TBL] [Abstract][Full Text] [Related]
10. Improved potency and specificity of Arg-Gly-Asp (RGD) containing peptides as fibrinogen receptor blocking drugs.
Foster MR; Hornby EJ; Brown S; Kitchin J; Hann M; Ward P
Thromb Res; 1993 Nov; 72(3):231-45. PubMed ID: 8303662
[TBL] [Abstract][Full Text] [Related]
11. Low molecular weight, non-peptide fibrinogen receptor antagonists.
Alig L; Edenhofer A; Hadváry P; Hürzeler M; Knopp D; Müller M; Steiner B; Trzeciak A; Weller T
J Med Chem; 1992 Nov; 35(23):4393-407. PubMed ID: 1447740
[TBL] [Abstract][Full Text] [Related]
12. Effects of hybrid peptide analogs to receptor recognition domains on alpha- and gamma-chains of human fibrinogen on fibrinogen binding to platelets.
Mohri H; Ohkubo T
Thromb Haemost; 1993 May; 69(5):490-5. PubMed ID: 8322271
[TBL] [Abstract][Full Text] [Related]
13. Halysin, an antiplatelet Arg-Gly-Asp-containing snake venom peptide, as fibrinogen receptor antagonist.
Huang TF; Liu CZ; Ouyang CH; Teng CM
Biochem Pharmacol; 1991 Aug; 42(6):1209-19. PubMed ID: 1888330
[TBL] [Abstract][Full Text] [Related]
14. Antiplatelet and antithrombotic effects of platelet glycoprotein IIb/IIIa (GPIIb/IIIa) inhibition by arginine-glycine-aspartic acid-serine (RGDS) and arginine-glycine-aspartic acid (RGD) (O-me)Y (SC-46749).
Nicholson NS; Panzer-Knodle SG; Salyers AK; Taite BB; King LW; Miyano M; Gorczynski RJ; Williams MH; Zupec ME; Tjoeng FS
J Pharmacol Exp Ther; 1991 Mar; 256(3):876-82. PubMed ID: 2005585
[TBL] [Abstract][Full Text] [Related]
15. Aminopeptidase resistant Arg-Gly-Asp analogs are stable in plasma and inhibit platelet aggregation.
Fok KF; Panzer-Knodle SG; Nicholson NS; Tjoeng FS; Feigen LP; Adams SP
Int J Pept Protein Res; 1991 Aug; 38(2):124-30. PubMed ID: 1783488
[TBL] [Abstract][Full Text] [Related]
16. Binding of [3H]-SK&F 107260 and [3H]-SB 214857 to purified integrin alphaIIbbeta3: evidence for a common binding site for cyclic arginyl-glycinyl-aspartic acid peptides and nonpeptides.
Wong A; Hwang SM; Johanson K; Samanen J; Bennett D; Landvatter SW; Chen W; Heys JR; Ali FE; Ku TW; Bondinell W; Nichols AJ; Powers DA; Stadel JM
J Pharmacol Exp Ther; 1998 Apr; 285(1):228-35. PubMed ID: 9536015
[TBL] [Abstract][Full Text] [Related]
17. Highly constrained cyclic (S,S) -CXaaC- peptides as inhibitors of fibrinogen binding to platelets.
Kouki A; Mitsios JV; Sakarellos-Daitsiotis M; Sakarellos C; Tselepis AD; Tsikaris V; Tsoukatos DC
J Thromb Haemost; 2005 Oct; 3(10):2324-30. PubMed ID: 16129021
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of human platelet aggregation by GR91669, a prototype fibrinogen receptor antagonist.
Foster MR; Hornby EJ; Brown S; Hann M; Kitchin J; Pike N; Ward P
Thromb Res; 1994 Aug; 75(3):269-84. PubMed ID: 7992238
[TBL] [Abstract][Full Text] [Related]
19. Modulation of vitronectin receptor-mediated osteoclast adhesion by Arg-Gly-Asp peptide analogs: a structure-function analysis.
Horton MA; Dorey EL; Nesbitt SA; Samanen J; Ali FE; Stadel JM; Nichols A; Greig R; Helfrich MH
J Bone Miner Res; 1993 Feb; 8(2):239-47. PubMed ID: 7680185
[TBL] [Abstract][Full Text] [Related]
20. The role of the RGD peptides and the gamma chain peptide of fibrinogen on fibrinogen binding to activated platelets.
Mohri H; Ohkubo T
Peptides; 1993; 14(2):353-7. PubMed ID: 8483813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
